Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 37 results.
User Information
Export Records
  1. 1.   Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor Treatment
  2. Huang,Yue; Nahar, Saifun; Alam, Md Masud; Hu, Shuo; McVicar,Dan; Yang,De
  3. ACS Nano. 2023, Oct 13;
  1. 2.   Role of stealth lipids in nanomedicine-based drug carriers
  2. Rastogi, Mehak; Saha, Ranendra Narayan; Alexander, Amit; Singhvi, Gautam; Puri,Anu; Dubey, Sunil Kumar
  3. Chemistry and Physics of Lipids. 2021, Mar; 235
  1. 3.   Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin disorders
  2. Waghule, Tejashree; Rapalli, Vamshi Krishna; Gorantla, Srividya; Saha, Ranendra Narayan; Dubey, Sunil Kumar; Puri,Anu; Singhvi, Gautam
  3. Current pharmaceutical design. 2020, Jun 14; 26(36): 4569-4579.
  1. 4.   Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting
  2. Agrawal, Mukta; Saraf, Swarnlata; Saraf, Shailendra; Dubey, Sunil Kumar; Puri,Anu; Patel, Ravish J.; Ravichandiran, V.; Murty, Upadhyayula Suryanarayana; Alexander, Amit
  3. Journal of controlled release : official journal of the Controlled Release Society. 2020, May 10; 321: 372-415.
  1. 5.   MDM1 is a microtubule-binding protein that negatively regulates centriole duplication
  2. Van de Mark, D.; Kong, D.; Loncarek, J.; Stearns, T.
  3. Molecular Biology of the Cell. 2015, 1-Nov; 26(21): 3788-802.
  1. 6.   Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles
  2. Altunbas, A.; Lee, S. J.; Rajasekaran, S. A.; Schneider, J. P.; Pochan, D. J.
  3. Biomaterials. 2011, Sep; 32(25): 5906-5914.
  1. 7.   Ductal Carcinoma In Situ: Detection, Diagnosis, and Characterization with Magnetic Resonance Imaging
  2. Jansen, S. A.
  3. Seminars in Ultrasound Ct and Mri. 2011, Aug; 32(4): 306-318.
  1. 8.   A Common HLA-DPA1 Variant is a Major Determinant of Hepatitis B Virus Clearance in Han Chinese
  2. An, P.; Winkler, C.; Guan, L.; O'Brien, S. J.; Zeng, Z.; Consortium, H. B. V. S.
  3. Journal of Infectious Diseases. 2011, Apr; 203(7): 943-947.
  1. 9.   Nanotechnology-Based Cancer Therapeutics-Promise and Challenge-Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
  2. Farrell, D.; Ptak, K.; Panaro, N. J.; Grodzinski, P.
  3. Pharmaceutical Research. 2011, Feb; 28(2): 273-278.
  1. 10.   Ethnoepidemiology of HTLV-1 related diseases: Ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal
  2. Sonoda, S.; Li, H. C. A.; Tajima, K.
  3. Cancer Science. 2011, Feb; 102(2): 295-301.
  1. 11.   A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubcin to cells
  2. Yavlovich, A.; Singh, A.; Blumenthal, R.; Puri, A.
  3. Biochimica Et Biophysica Acta-Biomembranes. 2011, Jan; 1808(1): 117-126.
  1. 12.   Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
  2. Gaudet, M. M.; Kirchhoff, T.; Green, T.; Vijai, J.; Korn, J. M.; Guiducci, C.; Segre, A. V.; McGee, K.; McGuffog, L.; Kartsonaki, C.; Morrison, J.; Healey, S.; Sinilnikova, O. M.; Stoppa-Lyonnet, D.; Mazoyer, S.; Gauthier-Villars, M.; Sobol, H.; Longy, M.; Frenay, M.; Hogervorst, F. B. L.; Rookus, M. A.; Collee, J. M.; Hoogerbrugge, N.; van Roozendaal, K. E. P.; Piedmonte, M.; Rubinstein, W.; Nerenstone, S.; Van Le, L.; Blank, S. V.; Caldes, T.; de la Hoya, M.; Nevanlinna, H.; Aittomaki, K.; Lazaro, C.; Blanco, I.; Arason, A.; Johannsson, O. T.; Barkardottir, R. B.; Devilee, P.; Olopade, O. I.; Neuhausen, S. L.; Wang, X. S.; Fredericksen, Z. S.; Peterlongo, P.; Manoukian, S.; Barile, M.; Viel, A.; Radice, P.; Phelan, C. M.; Narod, S.; Rennert, G.; Lejbkowicz, F.; Flugelman, A.; Andrulis, I. L.; Glendon, G.; Ozcelik, H.; Tol, A. E.; Montagna, M.; D'Andrea, E.; Friedman, E.; Laitman, Y.; Borg, A.; Beattie, M.; Ramus, S. J.; Domchek, S. M.; Nathanson, K. L.; Rebbeck, T.; Spurdle, A. B.; Chen, X. Q.; Holl, H.; John, E. M.; Hopper, J. L.; Buys, S. S.; Daly, M. B.; Southey, M. C.; Terry, M. B.; Tung, N.; Hansen, T. V. O.; Nielsen, F. C.; Greene, M. I.; Mai, P. L.; Osorio, A.; Duran, M.; Andres, R.; Benitez, J.; Weitzel, J. N.; Garber, J.; Hamann, U.; Peock, S.; Cook, M.; Oliver, C.; Frost, D.; Platte, R.; Evans, D. G.; Lalloo, F.; Eeles, R.; Izatt, L.; Walker, L.; Eason, J.; Barwell, J.; Godwin, A. K.; Schmutzler, R. K.; Wappenschmidt, B.; Engert, S.; Arnold, N.; Gadzicki, D.; Dean, M.; Gold, B.; Klein, R. J.; Couch, F. J.; Chenevix-Trench, G.; Easton, D. F.; Daly, M. J.; Antoniou, A. C.; Altshuler, D. M.; Offit, K.; kConFab, G. S. C. H. S. C. O.
  3. Plos Genetics. 2010, Oct; 6(10): 12.
  1. 13.   Semiconductor Nanocrystals in Autophagy Research: Methodology Improvement at Nanosized Scale
  2. Seleverstov, O.; Phang, J. M.; Zabirnyk, O.
  3. Autophagy in Mammalian Systems. 2009; 452, Pt B : 277-296.
  1. 14.   Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
  2. Puri, A.; Loomis, K.; Smith, B.; Lee, J. H.; Yavlovich, A.; Heldman, E.; Blumenthal, R.
  3. Critical Reviews in Therapeutic Drug Carrier Systems. 2009 26(6): 523-580.
  1. 15.   Hematologic and biochemical changes associated with human T lymphotropic virus type 1 infection in Jamaica: A report from the population-based blood donors study
  2. Chaturvedi, A. K.; Wilson, M.; Sanders-Lewis, K. A.; Katki, H. A.; Urquhart, N.; Walters, M. A.; Miley, W.; Cranston, B.; Hanchard, B.; Hisada, M.
  3. Clinical Infectious Diseases. 2007, Oct; 45(8): 975-982.
  1. 16.   Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer
  2. Wei, M. H.; Toure, O.; Glenn, G. M.; Pithukpakorn, M.; Neckers, L.; Stolle, C.; Choyke, P.; Grubb, R.; Middelton, L.; Turner, M. L.; Walther, M. M.; Merino, M. J.; Zbar, B.; Linehan, W. M.; Toro, J. R.
  3. Journal of Medical Genetics. 2006, JAN; 43(1): 18-27.
  1. 17.   Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma
  2. Kovacic, M. B.; Martin, M.; Gao, X. J.; Fuksenko, T.; Chen, C. J.; Cheng, Y. J.; Chen, J. Y.; Apple, R.; Hildesheim, A.; Carrington, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 1): 2673-2677.
  1. 18.   Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
  2. Lepper, E. R.; Baker, S. D.; Permenter, M.; Ries, N.; van Schaik, R. H. N.; Schenk, P. W.; Price, D. K.; Ahn, D.; Smith, N. F.; Cusatis, G.; Ingersoll, R. G.; Bates, S. E.; Mathijssen, R. H. J.; Verweij, J.; Figg, W. D.; Sparreboom, A.
  3. Clinical Cancer Research. 2005, OCT 15; 11(20): 7398-7404.
  1. 19.   Analysis of albumin-associated peptides and proteins from ovarian cancer patients
  2. Lowenthal, M. S.; Mehta, A. I.; Frogale, K.; Bandle, R. W.; Araujo, R. P.; Hood, B. L.; Veenstra, T. D.; Conrads, T. P.; Goldsmith, P.; Fishman, D.; Petricoin, E. F.; Liotta, L. A
  3. Clinical Chemistry. 2005, OCT; 51(10): 1933-1945.
  1. 20.   Determination of the stability constants and oxidation susceptibility of nickel(II) complexes with 2 '-de oxyguano sine 5 '-triphosphate and L-histidine
  2. Kaczmarek, P.; Jezowska-Bojczuk, M.; Bal, W.; Kasprzak, K. S.
  3. Journal of Inorganic Biochemistry. 2005, MAR; 99(3): 737-746.
  1. 21.   Importance of communication between producers and consumers of publicly available experimental data
  2. Liotta, L. A.; Lowenthal, M.; Mehta, A.; Conrads, T. P.; Veenstra, T. D.; Fishman, D. A.; Petricoin, E. F.
  3. Journal of the National Cancer Institute. 2005, FEB 16; 97(4): 310-314.
  1. 22.   Provirus load is lower in human T lymphotropic virus (HTLV)-II carriers than in HTLV-I carriers: A key difference in viral pathogenesis?
  2. Hisada, M.; Miley, W. J.; Biggar, R. J.
  3. Journal of Infectious Diseases. 2005 191(8): 1383-1385.
  1. 23.   Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests
  2. Ogino, S.; Flodman, P.; Wilson, R. B.; Gold, B.; Grody, W. W.
  3. Genetics in Medicine. 2005, MAY-JUN; 7(5): 317-327.
  1. 24.   Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma
  2. Huang, W. Y.; Chatterjee, N.; Chanock, S.; Dean, M.; Yeager, M.; Schoen, R. E.; Hou, L. F.; Berndt, S. I.; Yadavalli, S.; Johnson, C. C.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, JAN; 14(1): 152-157.
  1. 25.   New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations
  2. Ogino, S.; Wilson, R. B.; Gold, B.
  3. European Journal of Human Genetics. 2004, DEC; 12(12): 1015-1023.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel